Liquidia Technologies Reports Third Quarter 2018 Financial Results and Provides Corporate Update
31 oct. 2018 07h00 HE
|
Liquidia Technologies, Inc.
Completed enrollment of the safety portion of our Ph3 LIQ861 (INSPIRE) clinical trialTwo-week safety Ph3 LIQ861 data readout anticipated in the first quarter of 2019Dr. Stephen Bloch appointed as...